Dexmedetomidine-esketamine combo may reduce delirium in ICU patients
A clinical trial is investigating the efficacy of a dexmedetomidine-esketamine combination to reduce delirium in ICU patients.
Therapeutic Area
Therapeutic area intelligence for Sedation with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.